A Phase I, double-blind, randomised, placebo-controlled study investigating the cardiac safety of bimagrumab in healthy older adults.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Bimagrumab (Primary)
- Indications Muscular atrophy
- Focus Adverse reactions; Pharmacodynamics
- 21 Sep 2016 New trial record